Hyperosmolar hyperglycemic syndrome
1 paper
- Humans1
Latest
1 in 12 monthsJournal of Diabetes Investigation
Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study
Cohort study of 616 peopleSGLT2 inhibitors